Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07512271 · ClinicalTrials.gov registry record · NA
Generative AI Patient Education Module for Breast Oncology
A NA study, sponsored by University of California, San Francisco.
- Not yet
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT07512271: Clinical Trial NA study, sponsored by University of California, San Francisco.
NCT07512271 is a NA study that has not yet begun recruiting, run by University of California, San Francisco. The registered enrollment target is 35 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07512271, a NA study, has not yet begun recruiting, sponsored by University of California, San Francisco.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate sites.
Primary Outcome
Safety and Risk Assessment evaluates safety concerns based on provider responses using a 5-point Likert scale.
Interventions
- OTHER Survey (Participant)
- OTHER OpenEvidence CareConnect
- OTHER Survey (Provider)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2026-08-15 |
| Est. Completion | 2027-01-31 |
| Phase | NA |
What is known before NCT07512271 opens enrollment
NCT07512271 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Survey (Participant) is the first listed.
NCT07512271 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07512271 about?
NCT07512271 is a clinical study titled "Generative AI Patient Education Module for Breast Oncology". This study evaluates the safety, accuracy, and impact of an artificial intelligence (AI) tool designed to support patient education in breast cancer care for breast oncology patients under selected physicians care within the University of California, San Francisco breast cancer center and affiliate ...
What is the current status of trial NCT07512271?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2026-08-15. Estimated completion is 2027-01-31.
What interventions are being tested in trial NCT07512271?
The interventions under investigation include: Survey (Participant) (OTHER), OpenEvidence CareConnect (OTHER), Survey (Provider) (OTHER).
Who is sponsoring clinical trial NCT07512271?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07512271's enrollment target sits among peer trials
35 1564th of 2000 higher than 431 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI